Related Experiment Videos
Using 4-color flow cytometry to identify abnormal myeloid populations.
Steven J Kussick1, Brent L Wood
1University of Washington Department of Laboratory Medicine, Seattle, Wash, USA. skussick@u.washington.edu
Archives of Pathology & Laboratory Medicine
|August 30, 2003
Summary
Flow cytometry offers an objective method for diagnosing myelodysplastic syndromes (MDSs) and non-chronic myeloid leukemia myeloproliferative disorders (MPDs). This technique identifies abnormal myeloid maturation patterns, aiding in the detection of stem cell neoplasms.
Area of Science:
- Hematology
- Oncology
- Immunophenotyping
Background:
- Diagnosis of myeloproliferative disorders (MPDs) and myelodysplastic syndromes (MDSs) traditionally relies on clinical and morphologic assessments.
- Objective evidence via clonal cytogenetic abnormalities is found in only 30-40% of non-chronic myeloid leukemia (CML) MPDs and MDSs.
Purpose of the Study:
- To establish normal antigen expression patterns during myeloid maturation.
- To evaluate flow cytometry as an objective method for assessing stem cell neoplasm likelihood.
Main Methods:
- Retrospective analysis of 4-color flow cytometry data from over 400 bone marrow aspirates.
- Evaluation of patients suspected of having non-CML MPD or MDS.
Main Results:
- Identified reproducible antigen expression patterns in normal myeloid maturation and reactive settings.
- Flow cytometry identified over 90% of non-CML MPD and MDS cases with clonal cytogenetic abnormalities.
Conclusions:
- 4-color flow cytometry provides valuable, objective data for diagnosing non-CML MPDs and MDSs.
- It serves as a crucial addition to conventional diagnostic workups in experienced laboratories.